-
1
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
-
2
-
-
0026537186
-
The catastrophic antiphospholipid syndrome [editorial]
-
Asherson RA. The catastrophic antiphospholipid syndrome [editorial]. J Rheumatol 1992;19:508-12.
-
(1992)
J Rheumatol
, vol.19
, pp. 508-512
-
-
Asherson, R.A.1
-
3
-
-
0142260580
-
The catastrophic antiphospholipid syndrome-Asherson's syndrome
-
Piette JC, Cervera R, Levy RA, Nasonov EL, Triplett DA, Shoenfeld Y. The catastrophic antiphospholipid syndrome-Asherson's syndrome. Ann Med Interne Paris 2003;154:195-6.
-
(2003)
Ann Med Interne Paris
, vol.154
, pp. 195-196
-
-
Piette, J.C.1
Cervera, R.2
Levy, R.A.3
Nasonov, E.L.4
Triplett, D.A.5
Shoenfeld, Y.6
-
4
-
-
0346850621
-
Catastrophic antiphospholipid syndrome: Where do we stand?
-
Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum 2003;48:3320-7.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 3320-3327
-
-
Erkan, D.1
Cervera, R.2
Asherson, R.A.3
-
5
-
-
0038376616
-
Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines
-
Asherson RA, Cervera R, de Groot PR, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-4.
-
(2003)
Lupus
, vol.12
, pp. 530-534
-
-
Asherson, R.A.1
Cervera, R.2
de Groot, P.R.3
-
6
-
-
33746993589
-
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients
-
Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006;54:2568-76.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2568-2576
-
-
Bucciarelli, S.1
Espinosa, G.2
Cervera, R.3
-
7
-
-
0031947185
-
Thrombotic storm: When thrombosis begets thrombosis
-
Kitchens CS. Thrombotic storm: When thrombosis begets thrombosis. Am J Med 1998;104:381-5.
-
(1998)
Am J Med
, vol.104
, pp. 381-385
-
-
Kitchens, C.S.1
-
8
-
-
0034279727
-
Multi-organ dysfunction in the critically ill: Effects on different organs
-
Brealy D, Singer M. Multi-organ dysfunction in the critically ill: effects on different organs. R Coll Phys Lon 2000;34:428-36.
-
(2000)
R Coll Phys Lon
, vol.34
, pp. 428-436
-
-
Brealy, D.1
Singer, M.2
-
10
-
-
33745617094
-
Neutrophils in development of multiple organ failure in sepsis
-
Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006;368:157-69.
-
(2006)
Lancet
, vol.368
, pp. 157-169
-
-
Brown, K.A.1
Brain, S.D.2
Pearson, J.D.3
Edgeworth, J.D.4
Lewis, S.M.5
Treacher, D.F.6
-
11
-
-
0033958261
-
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome. Molecular mimicry?
-
Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome. Molecular mimicry? J Rheumatol 2000;27:12-4.
-
(2000)
J Rheumatol
, vol.27
, pp. 12-14
-
-
Asherson, R.A.1
Shoenfeld, Y.2
-
12
-
-
29144479891
-
Infectious origin of the antiphospholipid syndrome
-
Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006;65:2-6.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 2-6
-
-
Shoenfeld, Y.1
Blank, M.2
Cervera, R.3
Font, J.4
Raschi, E.5
Meroni, P.L.6
-
13
-
-
4644338190
-
Antiphospholipid syndrome associated with infections: Clinical and microbiological characteristics of 100 patients
-
Cervera R, Asherson RA, Acevedo ML, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004;63:1312-7.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1312-1317
-
-
Cervera, R.1
Asherson, R.A.2
Acevedo, M.L.3
-
14
-
-
0037180768
-
The immunopathogenesis of sepsis
-
Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-91.
-
(2002)
Nature
, vol.420
, pp. 885-891
-
-
Cohen, J.1
-
15
-
-
8844271818
-
Innate immunity in the antiphospholipid syndrome: Role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies
-
Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 2004;3:510-5.
-
(2004)
Autoimmun Rev
, vol.3
, pp. 510-515
-
-
Meroni, P.L.1
Raschi, E.2
Testoni, C.3
Parisio, A.4
Borghi, M.O.5
-
17
-
-
2442701758
-
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies
-
Espinosa G, Bucciarelli S, Cervera R, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004;63:730-6.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 730-736
-
-
Espinosa, G.1
Bucciarelli, S.2
Cervera, R.3
-
18
-
-
30444461242
-
Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure
-
Ono S, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006;107:528-34.
-
(2006)
Blood
, vol.107
, pp. 528-534
-
-
Ono, S.1
Mimuro, J.2
Madoiwa, S.3
-
19
-
-
21144442653
-
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: Clinical and haematological characteristics of 23 patients
-
Asherson RA, Espinosa G, Cervera R, et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 2005;64:943-6.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 943-946
-
-
Asherson, R.A.1
Espinosa, G.2
Cervera, R.3
-
20
-
-
34248672107
-
-
Asherson RA, Cervera R, Merrill JT. Thrombotic microangiopathic antiphospholipid syndromes: A continuum of conditions? Future Rheumatology 2006;1:355-64.
-
Asherson RA, Cervera R, Merrill JT. Thrombotic microangiopathic antiphospholipid syndromes: A continuum of conditions? Future Rheumatology 2006;1:355-64.
-
-
-
-
21
-
-
5644272713
-
Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome
-
Amoura Z, Costedoat-Chalumeau N, Veyradier A, et al. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. Arthritis Rheum 2004;50:3260-4.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3260-3264
-
-
Amoura, Z.1
Costedoat-Chalumeau, N.2
Veyradier, A.3
|